Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar ATPase assembly factor VMA12 (VMA12) is a transmembrane protein located in the endoplasmic reticulum (ER) that acts as a dedicated assembly factor (chaperone) for the membrane-embedded V0 sector of the vacuolar-type H+-ATPase (V-ATPase) proton pump. It participates in the recruitment and stabilization of V-ATPase membrane subunits during assembly, interacting with Vma22 and subunits a, e, and f to promote proper V-ATPase formation[1][3]. VMA12 is not part of the mature V-ATPase proton pump complex itself, but is essential for its biogenesis and quality control, ensuring only properly assembled complexes are exported from the ER. Mutations in the human orthologs (including TMEM199) result in congenital disorders of glycosylation and liver disease, as well as defects in endolysosomal acidification[1]. VMA12 is not a therapeutic target per se, and no known drugs directly target this assembly factor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar ATPase assembly factor VMA12 (VMA12).